Atlas Trials

Study of [177Lu]Lu-PSMA-137 In Metastatic Castrate Resistant Prostate Cancer(mCRPC)

Clinical trial NCT06546527 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06546527
Sponsor
Peking University First Hospital
Status
NOT_YET_RECRUITING
Phase
Early Phase 1
Study type
INTERVENTIONAL
Prostate Cancer
Start date
2024-08-01
Primary completion
2025-03-01
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.